Accuray (NSDQ:ARAY) today announced it appointed Sandeep Chalke as senior VP and chief commercial officer, effective May 16. Chalke will report to President and forthcoming CEO Suzanne Winter and will be responsible for the global commercial, product development, R&D and engineering functions of the Sunnyvale, California-based company. “I am thrilled to join the Accuray team and […]
Zimmer Biomet appoints new chief accounting officer
Zimmer Biomet (NYSE: ZBH) today announced that it appointed Paul Stellato as VP, controller and chief accounting officer. Prior to joining the Warsaw, Indiana-based company, Stellato was VP of finance and global business services at water tech company Xylem. He has also held numerous leadership roles at ITT Corporation, Arthur Andersen and Ernst & Young. […]
Zimmer Biomet introducing AI for its Omni Suite intelligent operating room
Zimmer Biomet (NYSE: ZBH) this week launched its artificial intelligence (AI) capabilities within its Omni Suite intelligent operating room. The Warsaw, Indiana–based company designed the intelligent OR to optimize surgical workflow and procedural efficiency by automating manual tasks. The newly-released AI feature uses cameras to automatically recognize and timestamp key OR workflow milestones, including patient […]
SmileDirectClub shares slide on mixed-bag Q1 results
SmileDirectClub (NSDQ:SDC) this week posted first-quarter results that beat the revenue consensus on Wall Street and missed earnings estimates. The Nashville, Tennessee-based dental aligner maker reported losses of $73.2 million, or -19¢ per share, on sales of $151.6 million for the three months ended March 31, on sales loss of 23.97% compared with Q1 2021. […]
Ocular Therapeutix posts mixed-bag Q1 results
Ocular Therapeutix (NSDQ:OCUL) this week posted first-quarter results that beat the earnings consensus on Wall Street but missed revenue estimates. The Bedford, Massachusetts-based company reported losses of $12.5 million, or -16¢ per share, on sales of $13.2 million for the three months ended March 31, for sales growth of 79.6% compared with Q1 2021. Earnings […]
Shockwave Medical grows sales 193% in Q1
Shockwave Medical (NSDQ:SWAV) this week posted first-quarter results that beat the overall consensus on Wall Street. The Santa Clara, California-based company reported profits of $14.5 million, or 39¢ per share, on sales of $93.6 million for the three months ended March 31, for a bottom-line gain from the year prior on sales growth of 193.5%. Earnings […]
Glaukos posts Street-beating Q1 results
Glaukos (NYSE:GKOS) this week posted first-quarter results that beat the overall consensus on Wall Street. The San Clemente, California-based company reported profits of $5.4 million, or 11¢ per share, on sales of $67.7 million for the three months ended March 31, for a sales loss of -0.42% compared with Q1 2021. Adjusted to exclude one-time items, […]
Silk Road Medical grows sales 27% in Q1 results
Silk Road Medical (NSDQ:SILK) this week posted first-quarter results that beat the revenue consensus on Wall Street and missed on earnings. The Sunnyvale, California-based stroke treatment tech company reported losses of $16.7 million, or -48¢ per share, on sales of $28.02 million for the three months ended March 31 for sales growth of 27% compared […]
OrthoPediatrics posts Street-beating Q1 results
OrthoPediatrics (Nasdaq:KIDS) this week posted first-quarter results that beat the overall consensus on Wall Street. The Warsaw, Indiana-based company reported losses of $9.1 million, or -47¢ per share, on sales of $23.4 million for the three months ended March 31, for a bottom-line gain of 12.3% on sales growth of 9.11% compared with Q1 2021. […]
Conmed beats The Street in Q1, announces $145M deal to acquire In2Bones
Conmed (NSDQ:CNMD) announced that it will acquire In2Bones Global for more than $145 million after it posted first-quarter results that beat the overall consensus on Wall Street. The Largo, Florida–based minimally invasive medical device company on yesterday evening reported profits of $14.96 million, or 47¢ per share, on sales of $242.3 million for the three […]
Conformis posts mixed bag Q1 results, grows sales 12%
Conformis (Nasdaq:CFMS) this week posted first-quarter results that beat the revenue consensus on Wall Street but missed earnings estimates. The Billerica, Massachusetts-based orthopedic device maker reported losses of $16 million, or -9¢ per share, on sales of $15.6 million for three months ended March 31, for a sales growth of 12.4% compared with Q1 2021. […]